Your browser doesn't support javascript.
loading
Presence but not number of secondary type mutations influences outcome in de novo AML without MDS-associated or recurring cytogenetic abnormalities.
Weinberg, Olga K; Cantu, Miguel D; Gagan, Jeffrey; Madanat, Yazan F; Arber, Daniel A; Hasserjian, Robert P.
Afiliação
  • Weinberg OK; Department of Pathology University of Texas Southwestern Medical Center Dallas Texas USA.
  • Cantu MD; Department of Pathology University of Texas Southwestern Medical Center Dallas Texas USA.
  • Gagan J; Department of Pathology University of Texas Southwestern Medical Center Dallas Texas USA.
  • Madanat YF; Department of Internal Medicine University of Texas Southwestern Medical Center Dallas Texas USA.
  • Arber DA; Harold C. Simmons Comprehensive Cancer Center University of Texas Southwestern Medical Center Dallas Texas USA.
  • Hasserjian RP; Department of Pathology University of Chicago Chicago Illinois USA.
EJHaem ; 4(3): 760-764, 2023 Aug.
Article em En | MEDLINE | ID: mdl-37601841
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article